Quacell Biotechnology, Co., Ltd., headquartered in Zhongshan City, Guangdong-Hong Kong-Macao Greater Bay Area, is a rapidly growing global biotechnology company. At present, the company has about 7000 square meters of modern biomedical innovation service platform, which covers culture medium development and production, cell line development to GMP pilot production.

Quacell adheres to the requirements of ISO and GMP regulations, and focuses on the research and manufacturing of cell culture medium, providing key raw materials for global biopharmaceutical and gene therapy enterprises. Focusing on customer requirements, it provides integrated services from DNA to GMP production in accordance with FDA/NMPA requirements and has won the recognition and trust of nearly 100 domestic and foreign biopharmaceutical and biotechnology enterprises.

Since its establishment, the company has obtained strategic investment from many well-known venture capital funds in the industry, including Shenzhen Capital Group CO., and National Venture Capital, and other institutions, and won many awards, including Pearl River Entrepreneurial Talent Enterprise, National Winning Project Enterprise of China Innovation and Entrepreneurship Competition, Top 50 "Potential Enterprises" of Guangdong-Hong Kong-Macao Greater Bay Area, and the Most Potential Leading Enterprise in Asia.The company is committed to becoming a global leader in industrial cell culture applications.